Merck & Co., Inc. (MRK) — Form 10-Q: Quarterly report

Merck & Co., Inc. filed its quarterly report for the period ended September 30, 2026. Worldwide sales reached $18.1 billion for the third quarter and $51.0 billion for the first nine months of 2026, representing 5% increases for both periods compared to 2025. Net income attributable to the company was reported on a GAAP and non-GAAP basis alongside updates on business development transactions and product performance.